Alfredo Addeo

Alfredo Addeo

UNVERIFIED PROFILE

Are you Alfredo Addeo?   Register this Author

Register author
Alfredo Addeo

Alfredo Addeo

Publications by authors named "Alfredo Addeo"

Are you Alfredo Addeo?   Register this Author

47Publications

260Reads

-Profile Views

Implementing circulating tumor DNA analysis in a clinical laboratory: A user manual.

Adv Clin Chem 2019;89:131-188. Epub 2019 Jan 28.

Service of Medical Genetics, Diagnostics Department, Geneva University Hospital, Geneva, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00652423183007
Publisher Site
http://dx.doi.org/10.1016/bs.acc.2018.12.004DOI Listing
May 2019

SABR versus conventional fractionation regimens in NSCLC.

Lancet Oncol 2019 May;20(5):e230

Department of Oncology, San Luigi Hospital University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30175-5DOI Listing
May 2019

Association of Industry and Academic Sponsorship With Negative Phase 3 Oncology Trials and Reported Outcomes on Participant Survival: A Pooled Analysis.

JAMA Netw Open 2019 May 3;2(5):e193684. Epub 2019 May 3.

Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2019.3684DOI Listing
May 2019

Atezolizumab plus Chemotherapy in Small-Cell Lung Cancer.

N Engl J Med 2019 02;380(9):888-889

Hôpitaux Universitaires de Genève, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1900123DOI Listing
February 2019

Corrigendum to "Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario" [Crit. Rev. Oncol./Hematol. 122 (February) (2018) 150-156].

Crit Rev Oncol Hematol 2018 Nov 2. Epub 2018 Nov 2.

Oncology Department, San Luigi Hospital University of Turin, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.06.018DOI Listing
November 2018

Learning from the past to design better trials in second-line treatment for mesothelioma patients.

Ecancermedicalscience 2018 12;12:881. Epub 2018 Nov 12.

Oncology Department, University Hospital Geneva, 1205 Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2018.881DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345074PMC
November 2018

Negative phase 3 randomized controlled trials: Why cancer drugs fail the last barrier?

Int J Cancer 2018 10 26;143(8):2079-2081. Epub 2018 Jul 26.

Oncology Department, University Hospital Geneva, Rue Gabrielle-Perret-Gentil 4, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31583DOI Listing
October 2018

Prophylactic Cranial Irradiation in Stage III Non-Small-Cell Lung Cancer: Overall Survival Should Not Necessarily Be the Final End Point.

J Clin Oncol 2018 Oct 22:JCO1800461. Epub 2018 Oct 22.

Alfredo Addeo, Francesca Caparrotti, Cristina Picardi, and Pierre-Yves Dietrich, University Hospital Geneva, Genève, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00461DOI Listing
October 2018

Immune-checkpoint inhibitors in non-small cell lung cancer: A tool to improve patients' selection.

Crit Rev Oncol Hematol 2018 Sep 23;129:27-39. Epub 2018 Jun 23.

Medical Oncology Unit, San Gerardo Hospital, Monza, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.06.016DOI Listing
September 2018

Atezolizumab Treatment of Nonsquamous NSCLC.

N Engl J Med 2018 09;379(12):1187

Hôpitaux Universitaires de Genève, Geneva, Switzerland

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1809195DOI Listing
September 2018

The crucial role of predicting brain metastases development in non-small cell lung cancer patients.

J Thorac Dis 2018 Sep;10(Suppl 26):S3305-S3307

Division of Medical Oncology, Cannizzaro Hospital, Via Messina 829, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.08.95DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6186638PMC
September 2018

PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Transl Lung Cancer Res 2018 Sep;7(Suppl 3):S283-S286

Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.

View Article

Download full-text PDF

Source
http://tlcr.amegroups.com/article/view/23046/18287
Publisher Site
http://dx.doi.org/10.21037/tlcr.2018.07.10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193909PMC
September 2018

PROS: should immunotherapy be incorporated in the treatment of oncogene-driven lung cancer?

Transl Lung Cancer Res 2018 Sep;7(Suppl 3):S287-S289

Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.

View Article

Download full-text PDF

Source
http://tlcr.amegroups.com/article/view/23044/18289
Publisher Site
http://dx.doi.org/10.21037/tlcr.2018.07.09DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193904PMC
September 2018

First-line alectinib for ALK-positive lung cancer: is there room for further improvement?

Drugs Context 2018 10;7:212537. Epub 2018 Jul 10.

Medical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7573/dic.212537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044318PMC
July 2018

Oral Metronomic Vinorelbine in Advanced Non-small Cell Lung Cancer Patients Unfit for Chemotherapy.

Anticancer Res 2018 Jun;38(6):3689-3697

Department of Biomedical and Biotechnological Sciences, Pathology and Oncology Section, University of Catania, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12647DOI Listing
June 2018

Statistical and Clinical Significance in the TERRA Study.

J Clin Oncol 2018 May 20;36(13):1379-1380. Epub 2018 Mar 20.

Paola Di Nardo, Bristol Oncology and Haematology Centre, Bristol, United Kingdom; and Alfredo Addeo, University Hospital Geneva, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.9595DOI Listing
May 2018

Adding an invasive procedure will not necessarily change treatment or outcome of NSCLC patients with preoperative clinical N1 disease.

Eur Respir J 2018 04 4;51(4). Epub 2018 Apr 4.

Division of Medical Oncology, Cannizzaro Hospital, Catania, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00084-2018DOI Listing
April 2018

Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario.

Crit Rev Oncol Hematol 2018 Feb 30;122:150-156. Epub 2017 Dec 30.

Oncology Department, San Luigi Hospital University of Turin, Orbassano, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.12.015DOI Listing
February 2018

Dacomitinib in NSCLC: a positive trial with little clinical impact.

Authors:
Alfredo Addeo

Lancet Oncol 2018 01;19(1):e4

Oncology Department, University Hospital Geneva, 1205 Geneva, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30923-3DOI Listing
January 2018

Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study.

BMC Palliat Care 2017 Dec 8;16(1):71. Epub 2017 Dec 8.

Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Southmead Hospital, 2nd Floor L&R Building, Bristol, BS10 5NB, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12904-017-0255-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5723074PMC
December 2017

Is There Room for Second-Line Treatment of Pleural Malignant Mesothelioma?

JAMA Oncol 2017 09;3(9):1170-1171

Department of Oncology, Mauriziano Hospital, University of Turin, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.6135DOI Listing
September 2017

Brain imaging before primary lung cancer resection: a controversial topic.

Ecancermedicalscience 2017 20;11:749. Epub 2017 Jun 20.

Bristol Cancer Institute, University Hospital Trust, Horfield Road, Bristol BS2 8ED, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3332/ecancer.2017.749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493439PMC
June 2017

Rushing will not help to choose the best combination.

Lancet Oncol 2017 04;18(4):e186

Department of Hemato-oncology, Nobel Hospital, Kathmandu, Nepal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30108-0DOI Listing
April 2017

Definition and estimation of osteonecrosis of jaw (ONJ), and optimal duration of antiresorptive treatment in bone metastatic cancer patients: supplementary data from the denosumab extension study?

Support Care Cancer 2017 02 9;25(2):345-349. Epub 2016 Mar 9.

Department of Surgical, Oncology and Oral Sciences - Sector of Oral Medicine, Palermo University, Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3147-9DOI Listing
February 2017

Intrathecal Methotrexate and Craniospinal Radiotherapy Can Be an Effective Treatment of Carcinomatous Meningitis in Patients with Breast Cancer: Case Reports.

Case Rep Oncol 2016 Sep-Dec;9(3):586-592. Epub 2016 Oct 12.

Bristol Cancer Institute, University Hospitals Bristol Foundation NHS Trust, Bristol, UK.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/449448
Publisher Site
http://dx.doi.org/10.1159/000449448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118826PMC
October 2016

LUX-Lung 7: is there enough data for a final conclusion?

Lancet Oncol 2016 07;17(7):e266

Bristol Cancer Institute, Bristol BS2 8ED, Somerset, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30116-4DOI Listing
July 2016

Do All High- and Intermediate-Risk Patients With Metastatic Castration-Resistant Prostate Cancer Really Benefit From Abiraterone?

J Clin Oncol 2016 Feb 23;34(4):387. Epub 2015 Nov 23.

Bristol Cancer Institute, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.8537DOI Listing
February 2016

Optimal Concurrent Chemoradiotherapy Regimen in Non-Small-Cell Lung Cancer: Prospective, Randomized Data Still Required.

J Clin Oncol 2015 Sep 27;33(26):2928. Epub 2015 Jul 27.

Bristol Cancer Centre, Bristol, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.61.7332DOI Listing
September 2015

Inferior mesenteric artery chemoembolization and chemotherapy for advanced rectal cancer: report of a clinical case.

Tumori 2015 Jun 25;101(3):e82-4. Epub 2015 Jun 25.

1 General Surgery Department, SG Bosco Hospital ASL To2, Turin - Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5301/tj.5000270DOI Listing
June 2015

Treatment with ipilimumab: a case report of complete response in a metastatic malignant melanoma patient.

Case Rep Oncol 2013 May 30;6(2):285-8. Epub 2013 May 30.

Departments of Oncology, United Lincolnshire Hospital Trust, Lincoln, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000351834DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725017PMC
May 2013

A case of abdominal sarcoidosis in a patient with acute myeloid leukemia.

Case Rep Hematol 2013 28;2013:379898. Epub 2013 Feb 28.

Department of Haematology, Pilgrim Hospital, Sibsey Road, Boston, PE21 9QS, Lincolnshire, UK.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/crihem/2013/379898/
Publisher Site
http://dx.doi.org/10.1155/2013/379898DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600231PMC
March 2013

Phytobezoar in Meckel's diverticulum: A rare cause of small bowel obstruction.

Int J Surg Case Rep 2012 3;3(5):161-3. Epub 2012 Feb 3.

Dept of General and Emergency Surgery, Ospedale SG Bosco, Piazza Donator di Sangue 3, Torino 10159, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijscr.2012.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316763PMC
October 2012

A case of small cell carcinoma of the prostate and review of the literature.

Tumori 2012 May-Jun;98(3):76e-78e

Oncology Department, United Lincolnshire Hospitals NHS Trust, Lincoln and Boston, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1700/1125.12415DOI Listing
October 2012

Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?

Lung Cancer 2008 Jul 19;61(1):73-81. Epub 2008 Feb 19.

Medical Oncology, Centro Oncologico Ematologico Subalpino (C.O.E.S.), Azienda Ospedaliera S. Giovanni Battista, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.12.007DOI Listing
July 2008

Activity of weekly paclitaxel in advanced hormone-refractory prostate cancer.

Am J Clin Oncol 2007 Jun;30(3):234-8

Centro Oncologico ed Ematologico Subalpino, Azienda Ospedaliera San Giovanni Battista, Corso Bramante 88, 10126 Torino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.coc.0000256706.16313.49DOI Listing
June 2007

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial.

Cancer Chemother Pharmacol 2006 Aug 6;58(2):203-9. Epub 2005 Dec 6.

Oncologia Medica, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliera Molinette, Via Cherasco 15, 10126 Torino, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-005-0157-6
Publisher Site
http://dx.doi.org/10.1007/s00280-005-0157-6DOI Listing
August 2006

Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response.

Cancer Biol Ther 2005 Feb 2;4(2):231-41. Epub 2005 Feb 2.

Department of Gastroenterology and Clinical Nutrition, Azienda Ospedaliera San Giovanni Battista, Molinette, Turin, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.4.2.1476DOI Listing
February 2005

A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine.

Anticancer Res 2004 Jul-Aug;24(4):2567-72

Oncologia Medica, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliera Molinette, Torino, Italy.

View Article

Download full-text PDF

Source
September 2004